Archives
‘Exercise hormone’ may play a role in combating Alzheimer’s disease
14 January 2019
This article has been reproduced from the NHS website. “An ‘exercise pill’ mimicking the effects of a gym workout could prevent Alzheimer’s disease,” the Daily Mirror reports. The “pill” is actually a reference to a protein called irisin. Irisin has been dubbed the “exercise hormone” because previous research found it’s released from muscles in response to […]
The ‘Neuroinflammation’ Study
26 February 2016
This is a study looking to recruit twenty people who do not have dementia. How does it work? The Neuroinflammation and Amyloid study will be taking an indepth look at exactly what happens to the brain in the earliest stages of Mild Cognitive Impairment, a condition which can develop to full Alzheimer’s Disease in 10-15% of […]
The ‘PREVENT’ Study
This study is looking at the prevention of dementia through environmental intervention, and is based at Imperial College London. Aims of the Study In recent years it has been recognised that dementia is probably a very late consequence of Alzheimer’s disease, or other neurodegenerative diseases, which may have been present in people for up to 20 or […]
The ‘YOAD’ Study
This study is based at University College London’s dedicated Dementia Research Centre and is looking into Young Onset Alzheimer’s Disease. How does it work? Alzheimer’s disease is the most common cause of dementia at any age, but around 40,000 people a year can develop symptoms of the condition before 65. Because it is much less common, researchers are still discovering how Young Onset Alzheimer’s Disease (YOAD) […]
The ‘GE180′ Study
This study is looking at a brand new way of mapping the brain, and how it is affected by dementia. How does it work? GE180 is a special chemical devised by researchers to latch on to the proteins, called Amyloids, that cause inflammation of the brain for people with Alzheimer’s Disease. The chemical then allows us […]
The ‘IDEAL’ Study
Aims of the Study IDEAL is the first large-scale project of its kind, and what the researchers find out will be used to guide policy and practice for helping people deal with dementia. As we get older we experience various changes in memory and other abilities which can affect our well-being and quality of life. […]
The ‘GREAT’ Study
The GREAT study – Goal-oriented cognitive Rehabilitation in EArly sTage dementia looks at how talking to a therapist can really help people handle problems with their memory. Aims of the Study The GREAT trial is a large research study that looks at ways of helping people to live well with memory difficulties. The research team wants to […]
The ‘AMPLE’ Study
The ‘AMPLE’ study, which is based at the University of Newcastle upon Tyne, investigates ‘amyloid imaging’ for the observable characteristics of Dementia with Lewy Bodies (DLB), which is the second most common cause of degenerative dementia in the UK. Beta-amyloid is a protein, deposits of which can be found in the brain of a person who has Alzheimer’s Disease. Until recently, […]
‘Deep and Frequent Phenotyping’
The ‘Deep and Frequent Phenotyping’ Study hopes to produce new ways of diagnosing dementia before symptoms even arise. Aims of the Study We urgently need new and better treatments that can be given to patients as early as possible to prevent brain damage associated with dementia. Researchers want to do studies before brain damage has progressed […]
The Gantenerumab Trial
This study looks at an exciting opportunity to get involved in testing new medication for people with Alzheimer’s Disease. Aims of the Study Alzheimer’s disease is a major global public health problem, and there are nearly 30 million people with the disease worldwide. Alzheimer’s disease is an irreversible, progressive neurodegenerative disease which causes a gradual […]